Drug clinical trial landscape of chronic myeloid leukemia: achieving the endpoint or continuing the journey?
J Transl Med
.
2024 Nov 26;22(1):1065.
doi: 10.1186/s12967-024-05882-5.
Authors
Shiyu Yang
#
1
2
,
Xia Jiang
#
1
2
,
Haihui Zhuang
1
2
,
Fenglin Li
1
2
,
Ying Lu
3
4
Affiliations
1
Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China.
2
Institute of Hematology, Ningbo University, Ningbo, China.
3
Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China. rmluying@nbu.edu.cn.
4
Institute of Hematology, Ningbo University, Ningbo, China. rmluying@nbu.edu.cn.
#
Contributed equally.
PMID:
39593036
DOI:
10.1186/s12967-024-05882-5
No abstract available
Publication types
Letter
Grants and funding
No.2022-S05/NINGBO Medical & Health Leading Academic Discipline Project